Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Completes Cargo Management Group Acquisition, Focuses on Long-Term Shareholder Value

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. According to the announcement, the transaction involved using 10% of the profits from GTVH’s logistics business to buy back and retire GTVH stock, which effectively reduced the number of outstanding shares on a consistent basis as profits are realized. This move represents Golden Triangle Ventures focus on driving long-term value for its shareholders. The company noted that Cargo Management Group reported nearly $3 million in revenue for 2023; the acquisition is expected to streamline internal operations, yield significant cost savings and bolster cash flow, thereby enhancing the Golden Triangle’s business margins. “This initiative marks the first of several strategies we plan to implement that aim to optimize our capital structure within GTV,” said Golden Triangle Ventures president Steffan Dalsgaard in the press release. “Our goal is to develop true fundamental business activities that support all of our operations. We have successfully implemented the first part of our four-pillar business model that supports Lavish Entertainment and our flagship Destino Ranch project, and our team is now focused on executing a series of other promising developments. These efforts are designed to further our objective of increasing shareholder value across all facets of our company.”

To view the full press release, visit https://cnw.fm/8X6q8

About Golden Triangle Ventures Inc.

Golden Triangle Ventures is a multifaceted consulting company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors along with others that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen its products and/or services. The three points of the Golden Triangle exclusively represent the three sectors the company aims to do business in. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the company. An amazing team of professionals support each division and continue to help Golden Triangle Ventures grow daily. For more information about the company, please visit www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Alternative Products Expo to Showcase Tradeshow At Houston

Cultivators, manufacturers, entrepreneurs, traders, and enthusiasts, are invited to attend the Alternative Products Expo being held June 20-22, 2024, at the George R. Brown Center, in Houston. With its dynamic vibe of food, culture, art, and pulsating nightlife, Houston is the perfect venue for the Alternative Products Expo.

The Altpro Expo in Houston is hosted by USA CBD Expo, America’s leading CBD and Hemp Expo event organizers. Over recent years, they have expanded to include the full alternative products range ecosystem. Organized by ZJ Events, the Expo caters to the industry’s best CBD traders, manufacturers, and enthusiasts offering an exciting learning experience under a common arena.

With the Houston smoke shop scene in full swing, this year’s Expo is expected to showcase over 500 smoke shops, with numbers rising every year. Both emerging and seasoned brands benefit tremendously by exhibiting their products and services to the Expo’s crowd of enthusiastic audiences.

The Alternative Products Expo offers a phenomenal networking opportunity, where industry people can connect and collaborate with leading brand experts and manufacturers for long-term ROI. Attendees will discover the latest trends and novel ideas currently leading the industry. Exhibitors can showcase their unique offerings to grab a bigger share of the market. Traders can leverage the best show deals as fresh products are introduced with limited-time offers. Also, get updated on the latest regulations and learn the future course of the Alternative Products markets.

Trinity Hemp is the presenting sponsor of Alternative Products Expo Houston.

To learn more, please visit https://cnw.fm/cCKMY

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Patent Portfolio to 43 Granted Patents Worldwide

  • Lexaria recently received two new patents granted in the U.S. in its patent families #21 and #24
  • The new patents complement the company’s efforts in investigating the capabilities of DehydraTECH-CBD to lower blood pressure in humans with hypertension and mitigate epileptic seizures in rodents
  • The company relies on R&D to provide data that enables it to apply for patent protection, supports further investigations and discoveries, as well as increases its chances of potentially receiving FDA approvals
  • According to CEO Chris Bunka, the company’s growing patent portfolio forms the foundation upon which the company forges commercial relationships

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, started 2024 with a portfolio of 38 patents granted worldwide, having received ten new granted patents during 2023, the most yet in a single year. That patent portfolio, company CEO Chris Bunka explained in his 2024 letter to shareholders, provides vital support for Lexaria’s commercialization efforts as it forms “the foundation upon which future commercial relationships are built.” Yet, according to the letter, the company continues to expect additional patents to be awarded in the future and retains many valid patent applications throughout the world (https://cnw.fm/Bb3nv).

This year, the company has received five new patents, growing its portfolio to 43 granted patents worldwide. This follows the April receipt of three new patents and the most recent announcement of two important new patent awards captured in a May 2024 news release.

According to the announcement, Lexaria received a new granted patent in its patent family #21: Compositions and Methods for Treating Hypertension. This is the company’s third granted U.S. patent in this patent family. Lexaria also reported the receipt of a new granted patent in its patent family #24: Compositions and Methods for Treating Epilepsy. This is the company’s third granted U.S. patent in this patent family (https://cnw.fm/6eFfU).

The company’s growing list of granted patents results from early and ongoing R&D. According to Mr. Bunka, Lexaria uses study-dependent data from studies to confidently support its patent applications. But besides serving the “purpose of allowing us to more confidently apply for patent protection using the study-dependent data,” the studies provide data to potentially support further investigations and discoveries, as well as potential approvals by the U.S. Food and Drug Administration (“FDA”).

This approach, coupled with the long-term vision, has enabled the company to investigate the capabilities of various active pharmaceutical ingredients processed using its patented DehydraTECH(TM) drug delivery technology in human and animal studies. For instance, Lexaria has investigated the ability of DehydraTECH-processed cannabidiol (“CBD”) to potentially treat hypertension in humans and mitigate epileptic seizures in rodents. These applications are partly or wholly protected by the recently granted patents.

Lexaria has repeatedly demonstrated that DehydraTECH-CBD has shown an ability to lower blood pressure in both acute dosing in hypertension and over a 5-week study duration. In a series of four hypertension studies, the company evidenced DehydraTECH-CBD’s ability to lower human blood pressure (https://cnw.fm/YuYG6), including in cases where the treatment was administered over an extended period (https://cnw.fm/ukRzo). The fourth study also led to the discovery of a potentially novel mechanism of action of DehydraTECH-CBD (https://cnw.fm/MjOjt).

These positive results encouraged the company to begin the process of seeking approval from the FDA to conduct a Phase 1b randomized, double-blind, placebo-controlled study of the safety, pharmacokinetics, and pharmacodynamics of DehydraTECH-CBD for the treatment of stage 1 or 2 hypertension. The company received earlier this year the FDA clearance to conduct the study (https://cnw.fm/Yo9IO) and will provide updates on the status of this planned study in due course.

Beyond the treatment of hypertension, Lexaria has demonstrated, through an animal study, that DehydraTECH-CBD reduces or eliminates seizure activity in animals and, in some cases, even surpasses the performance of Epidiolex(R), one of the world’s leading anti-seizure medications. The company also reported that DehydraTECH-CBD suppresses body weight, improves triglyceride/cholesterol levels, and reduces blood glucose levels in an animal diabetes study.

The successes of these animal studies have supported the possibility of conducting additional human clinical studies of DehydraTECH-CBD. In addition to investigating DehydraTECH-CBD’s capabilities, Lexaria is also looking at the potential application of its drug delivery technology to GLP-1 drugs.

Supported by a robust growing portfolio of granted patents and encouraged by the positive results from its R&D activities, Lexaria continues to forge ahead, aiming to achieve its future business objectives.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Marijuana Reclassification Could Result in Greener Farming Methods

Could the reclassification of cannabis lead to significant reductions in energy consumption by commercial marijuana cultivators and overall improvement in the industry’s environmental impact?

It’s well-known that indoor marijuana cultivation facilities have a major environmental and energy footprint. This is largely due to the massive electricity consumption required for robust HVAC systems, horticultural lighting, and numerous fans and pumps needed to create optimal growing conditions.

Although the exact details of a post-scheduling cannabis industry in the United States are unknown, we can learn from the controlled-environment agriculture (CEA) industry about potential changes in cannabis growing, such as the adoption of less energy-intensive techniques.

Reclassification could unlock a variety of federal programs that are currently inaccessible to cannabis entities due to federal prohibition.

The Biden administration allocated billions for agricultural and clean-energy projects in 2022 through the Inflation Reduction Act. For instance, the U.S. Department of Agriculture (USDA) has, through loan guarantees and grants, helped domestic CEA enterprises install efficient and sustainable energy technologies. These include chillers, heat pumps, LED grow lights, clean-power generation and sophisticated HVAC systems.

The program works better for larger institutions due to the significant administrative effort associated with applying for USDA assistance.

Nonetheless, CEA companies of all sizes can obtain support navigating USDA grant and loan applications from a number of federal grant aid organizations. The IRS provides a 30% investment tax credit for marijuana companies that want to install renewable energy sources, such as solar panels, on their property.

Developers of cultivation facilities sometimes point to the high upfront costs as a primary deterrent to the installation of cutting-edge, energy-efficient machinery. Rescheduling could free operators from the restrictions imposed by Section 280E of the IRS, which levies greater taxes on corporations that handle plants than on conventional enterprises. This might free up funds, allowing numerous operators to modernize their spaces for increased energy efficiency.

As of right now, indoor facilities are not subject to any national codes; however, this could change in the future when the International Energy Conservation Code is updated. States that enforce clean-air vehicle requirements, such as California, may, in the meantime, implement more stringent regulations than those established by the federal government.

In the meanwhile, multistate cannabis companies will have to manage a complicated web of regulations.

The potential reclassification of cannabis presents a great opportunity to make the industry more environmentally sustainable. It’s imperative that marijuana businesses keep up with constantly changing federal regulations and proactively implement clean, energy-efficient technology.

Compared to outdoor farms or traditional greenhouses, indoor agriculture requires a lot more electricity per square foot yet permits year-round production regardless of the weather. In the event that cannabis becomes legally transferable across state lines, growers may decide to move from costly indoor models in the north to more affordable outdoor or greenhouse settings in the South and west.

Although this transition could take decades, shifting production to more naturally conducive areas would significantly lessen the industry’s overall environmental footprint.

As the anticipated regulatory change is still very much in flux, entities such as SNDL Inc. (NASDAQ: SNDL) are likely to observe and later decide how best to leverage the changed regulatory landscape in order to further optimize their operations.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Alternative Products Expo Returns to Texas for Flagship Global Counterculture Event

Alternative Products Expo (Alt Pro Expo) is preparing to kick off its next in a series of blowout events across North and South America. Presented by ZJ Evets, Alt Pro Expo is slated for June 20–22, 2024, in Houston, Texas. Through the years, Alt Pro Expo has built a reputation for creating a flagship series of events in the global counterculture industry. The agenda for the networking festival includes invaluable education while the exhibit area spotlights an incredible portfolio of innovative products, including vape and hemp products, CBD, disposables, kratom, mushrooms, functional beverages, dietary supplements, nootropics, nicotine replacement, energy enhancers, mood changers and other accessories. The event offers an unparalleled opportunity for hundreds of top manufacturers, buyers, suppliers, innovators, vendors, researchers, budding entrepreneurs and seasoned industry professionals to gather together. “The Alternative Products Expo is the flagship series for the global counterculture industry and is the preeminent platform for nurturing professional networks, building market presence, and fine-tuning market entry strategies,” said Alt Pro Expo director of partnerships Sebastian Carmona in the press release. “Following the raging success of the Dallas event last year, we are thrilled to be returning to the great state of Texas to help drive participation and innovation in the vape, smoke shop and the broader alternative products sector. The upcoming expo is a must-attend for fresh business owners and vendors, established industry players, enthusiastic consumers, and curious newcomers.”

To attend the event, visit https://cnw.fm/fTtra

To view the full press release, visit https://cnw.fm/WVLn7

About Alternative Products Expo

Alternative Products Expo, formerly USA CBD Expo, is a production of ZJ Events. Company founders were once exhibitors who, after attending countless trade show events, saw an opportunity to build upon their experience and create an event that combined the best they had seen, with their own notion of what was missing in these business gatherings. By bringing the alternative community together, the company seeks to provide industry professionals from all corners of the market with an immersive and unique opportunity for networking and business expansion. For more information about the company, visit www.AltProExpo.com.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates completion of the final arm of the study, GLP-1-H24-2, in July. A three-arm, crossover investigation that compares three 7 mg semaglutide dose formulations, the study evaluates three doses: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsule; and for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. The study is designed to measure tolerability and side effects as well as semaglutide and blood glucose levels. Rybelsus (semaglutide) is the only GLP-1 drug approved by the FDA for oral dosingto treat diabetes and weight loss. “Blood samples will be taken multiple times during the first 10 hours post dosing,” the company stated in the press release. “A final blood draw will be taken 24 hours after dosing, and a standardized meal will be fed to the test subjects at a point in time after dosing. Nine healthy subjects are expected to be dosed with each test article with roughly a 30-day ‘washout’ interval between each dosing visit.

To view the full press release, visit https://cnw.fm/BZSDc

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery formulation and processing platform technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 43 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Study Finds Adolescents’ Use of Marijuana Heightens Psychotic Disorders Risk

A recent study featured in the “Psychological Medicine” journal delves into the relationship between adolescent marijuana use and the development of psychotic disorders. The research indicates a significant increase in psychotic disorder risks during adolescence linked to marijuana use, a risk that is particularly pronounced with the stronger marijuana products available today. Interestingly, this increased risk does not extend into young adulthood.

Previous studies have suggested a link between youth marijuana use and psychotic disorders, noting a higher likelihood of such disorders among marijuana users. These earlier studies often relied on outdated data when marijuana was less potent and faced limitations such as small sample sizes and less clinically significant outcomes.

The recent study assessed the relationship between teenage marijuana usage and the likelihood of receiving a clinical diagnosis of a psychotic condition using more recent population-based statistics. The goal of the research was to bring the findings up to speed with the current increase in marijuana potency.

Data were drawn from the Canadian Community Health Survey (CCHS) between 2009 and 2012, linked with Ontario’s administrative health records. The study focused on Ontario residents aged 12 to 24 years of age. Those with incomplete medical records or a history of psychotic disorders were excluded, resulting in a final sample of 11,363 participants.

Information on marijuana use and other substance usage, along with sociodemographic details was collected through interviews conducted both by phone and in person. The follow-up ended in 2018 after a maximum of nine years of monitoring the participants. The analysis accounted for various confounding factors, including sex, age, race, other drug use and income.

Approximately 23.4% of respondents reported using marijuana in the past 12 months, and during the follow-up, 1.2% sought healthcare for psychotic disorders. The analysis revealed a significant association between psychotic disorders and recent marijuana use among adolescents aged 12 to 19 years of age, with an adjusted hazard ratio of 11.21. This was not found in young adults aged 20 to 33 years of age, who had an aHR of 1.29.

Subsequent analysis supported these results, demonstrating an aHR of 26.68 for adolescent cannabis users’ hospitalizations or doctor visits linked to psychotic illnesses. Additionally, a dose-response association was noted, with an aHR of 10.70 indicating that frequent marijuana use among teenagers was associated with a higher risk. An analysis focusing on gender revealed that this link, with an aHR of 9.98, was significant for teenage males.

Additionally, the study discovered a substantial correlation between cannabis usage in the year prior and the utilization of healthcare services for psychotic disorders in the past, indicating a possible reverse causal relationship.

The study’s strengths include the use of representative and high-quality data from the CCHS and linked health records, as well as a validated outcome measure and recent cannabis potency data. However, limitations include a single baseline assessment, self-reported marijuana use, and possible unmeasured confounding measures including family history, trauma and genetic predispositions.

These findings hold important implications for public policy and health, especially concerning the prevention of teenage marijuana use.

This elevated risk of adolescents developing psychosis when they use marijuana makes a strong case for allowing legal marijuana sales by licensed companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) in states because guardrails, including verifying the age of a product buyer, can be implemented to make it harder for teens to access marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Completes Strategic Acquisition

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced the successful completion of its acquisition of Cargo Management Group, a reputable and longstanding shipping, logistics and trucking operation, from TK Zarro, LLC. The acquisition marks a significant milestone in GTV’s expansion efforts, as well as enhancing its operational capabilities within its Lavish Entertainment division and providing a full suite of in-house logistics capabilities for other company operations. Cargo Management Group reported nearly $3 million in revenue for 2023 and brings a robust portfolio of contracts with industry leaders such as JB Hunt, CH Robinson, Coyote Logistics, and Echo Logistics. “The acquisition of Cargo Management Group is a transformative step for GTV. This deal provides a scalable business model that will support both Lavish Entertainment and the development of our future flagship project, Destino Ranch,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “This business, its income, and our recently completed renegotiations on our outstanding note will dramatically impact our balance in a positive manner. Additionally, this helps move GTV toward its goal of becoming a highly profitable company with minimal to zero debt and a diverse asset portfolio.”

To view the full press release, visit https://cnw.fm/xlWw2

About Golden Triangle Ventures Inc. (“GTV”)

Golden Triangle Ventures is a multifaceted consulting company, which operates as the parent business pursuing ventures in the health, entertainment and technology sectors, along with others that provide synergistic value to these three core divisions. The company aims to purchase, acquire and/or joint venture with established entities within these areas of business. The goods and services represented are driven by innovators who have passion and commitment in these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent the three sectors in which this company aims to do business. Golden Triangle Ventures is highly focused on acquiring a well-diversified portfolio of companies under one umbrella, which are all managed and owned by the company. An amazing team of professionals support each division and continue to help the company grow daily. Being a publicly traded company gives the ability to provide the support needed to help each subsidiary grow into the business that management believes it can and will become. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

420 with CNW — Police Groups Support Bill to Authorize Cannabis Interstate Commerce, End Federal Prohibition in States

A bipartisan initiative aiming at terminating federal enforcement of marijuana laws in states where it is legal has the backing of two significant law enforcement organizations: the Oregon Coalition of Police and Sheriffs (ORCOPS) and the Peace Officers Research Association of California (PORAC). The huge tobacco and alcohol businesses are among the members of the Coalition for Cannabis Policy, Education, and Regulation (CPEAR), which made this endorsement announcement.

The bill, known as the STATES 2.0 Act, has gained backing from prominent lawmakers, including Representative Dave Joyce, the primary sponsor. Joyce, a former prosecutor, expressed gratitude toward the law enforcement associations for their support, emphasizing the inefficiency and counterproductive nature of forcing officers to navigate conflicting state and federal cannabis laws. He highlighted that this bill would resolve these discrepancies, allowing law enforcement to better focus on public-safety and community-specific needs.

Other sponsors of the bill include Representatives Brian Mast, Troy Carter, Lori Chavez-DeRemer and Earl Blumenauer. The proposed legislation seeks to amend the CSA, thereby decriminalizing federal offenses for individuals complying with state marijuana laws and those of Indian tribes. It also aims to authorize interstate cannabis commerce and proposes a tax on marijuana to support enforcement and regulation efforts.

Brian Marvel, president of PORAC, praised the STATES 2.0 Act, noting its balance between federal oversight and state autonomy. He emphasized that while state-level legalization does not eliminate illegal markets, the act would help law enforcement target those markets more effectively. This would enable understaffed and underfunded agencies to allocate resources toward more serious crimes and illegal substances.

ORCOPS president Aaron Schmautz underscored the importance of state and federal cooperation in ensuring laws and policies achieve their intended outcomes. He highlighted the longstanding disconnect between federal marijuana regulations and state legalization efforts, affirming that the STATES 2.0 Act addresses this issue and promotes public safety and responsible marijuana policies nationwide.

Additionally, the bill includes provisions to remove cannabis sales subject to state regulation from Section 280E of the IRS code, which now prohibits the industry from claiming federal tax deductions that are available to other markets. Following the bill’s passage, the attorney general would have six months to complete a rule modifying the CSA to exempt states and tribes from the federal government’s prohibition on cannabis use.

Former Representative Greg Walden, cochair of CPEAR, emphasized the bill’s respect for state rights and its potential to resolve conflicts arising from outdated federal policies. Walden, whose views on cannabis policy evolved during his time in Congress, now advocates for aligning federal laws with state regulations, reflecting the will of voters and supporting law enforcement.

The executive director of CPEAR, Andrew Freedman, praised the STATES Act for encouraging reasonable drug-policy reform and coordinating federal policy with state initiatives. He emphasized the necessity of laws that safeguard children, improve traffic safety, fight addiction and honor local marijuana laws.

Additionally, CPEAR emphasized a recent survey that found more than 60% of Republicans are in favor of congressional legislation that preserves states’ autonomy to enact cannabis regulations. The bipartisan appeal of the STATES 2.0 Act is highlighted by this broad support.

The momentum in favor of federal marijuana policy reform is growing, and marijuana companies such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) can believe that change is likely to come sooner rather than later.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN

10th Annual CWCBExpo To Witness Major Players Discussing Key Market Trends 

The CWCBExpo is an essential B2B expo on the East Coast, being held at the Javits Convention Center in New York City. This year the Expo will be held from June 5-6, 2024, for two days of networking and engaging educational sessions.

The event schedule is meticulously planned as follows:

  • June 4, 2024 – The exhibitors set up their booths, the pre-workshops are conducted on cultivation and operating a dispensary, and attendees can connect with industry colleagues at the rooftop bash that night.
  • June 5, 2024 – After the registration and the media and press preview, the expo commences with a ribbon-cutting event. The expo floor opens and conference programs are conducted.
  • June 6, 2024 – The attendees can participate in the conference programs and visit the expo on both the days. Along with business and networking, the participants can unwind, enjoy, and connect with industry influencers and peers at the luncheons, and after parties hosted by CWCBExpo on both the days.

Prominent members of the cannabis industry will share important insights, including:

  • Industry icon Josh Kesselman, Founder and CEO, of HBI International / RAW Rolling Papers, who will preside over the fireside chat/keynote speaker session.
  • Cy Scott, Co-Founder, CEO, of Headset, who will offer his insightful industry update on why New York is the next big cannabis market to watch out for and provide an update on rescheduling.

A special luncheon focusing on women in the cannabis business will be held on June 5, 2024. CWCBExpo is a leading B2B marketplace for networking within the cannabis community. Become a part of the interactive educational sessions, see unique product displays, participate in panel discussions, and seek the phenomenal opportunities offered by the CWCBExpo platform.

To learn more please visit https://cnw.fm/kVPAd & https://cnw.fm/O42wb.

About CannabisNewsWire

CannabisNewsWire (“CNW”) is a specialized communications platform with a focus on cannabis news and the cannabis sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled recognition and brand awareness. CNW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer

CannabisNewsWire
Denver, CO
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is powered by IBN